Log in

NASDAQ:BCLIBrainstorm Cell Therapeutics News Headlines

$12.48
+0.33 (+2.72 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$11.88
Now: $12.48
$12.56
50-Day Range
$5.82
MA: $9.05
$12.66
52-Week Range
$3.43
Now: $12.48
$13.61
Volume680,900 shs
Average Volume919,748 shs
Market Capitalization$367.41 million
P/E RatioN/A
Dividend YieldN/A
Beta1.12

Headlines

Brainstorm Cell Therapeutics (NASDAQ BCLI) News Headlines

Source:
DateHeadline
BRIEF-Brainstorm Cell Files Prospectus Supplement Offering 2.5 Mln SharesBRIEF-Brainstorm Cell Files Prospectus Supplement Offering 2.5 Mln Shares
www.reuters.com - July 4 at 12:29 PM
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALSBrainStorm Announces Completion of All Dosing in NurOwn® Phase 3 Clinical Trial in ALS
finance.yahoo.com - July 2 at 11:51 AM
BrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL WebinarBrainStorm to Showcase Alzheimer's Disease Clinical Program in KOL Webinar
finance.yahoo.com - July 1 at 12:49 PM
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Upgraded to Strong-Buy by BidaskClubBrainstorm Cell Therapeutics (NASDAQ:BCLI) Upgraded to Strong-Buy by BidaskClub
www.marketbeat.com - June 26 at 5:12 AM
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimers DiseaseBrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease
www.prnewswire.com - June 24 at 10:22 AM
BrainStorm to develop NurOwn for AlzheimersBrainStorm to develop NurOwn for Alzheimer's
seekingalpha.com - June 24 at 10:22 AM
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's DiseaseBrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer's Disease
finance.yahoo.com - June 24 at 10:22 AM
BrainStorm to study stem cell treatment in Alzheimer's patientsBrainStorm to study stem cell treatment in Alzheimer's patients
finance.yahoo.com - June 24 at 10:22 AM
BrainStorm Cell to join Russell 2000 and 3000 indexesBrainStorm Cell to join Russell 2000 and 3000 indexes
seekingalpha.com - June 23 at 8:10 AM
BrainStorm Cell Therapeutics to Join the Russell 2000® Index and Russell 3000® IndexBrainStorm Cell Therapeutics to Join the Russell 2000® Index and Russell 3000® Index
finance.yahoo.com - June 23 at 8:10 AM
Zacks: Brokerages Anticipate Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Will Announce Earnings of -$0.24 Per ShareZacks: Brokerages Anticipate Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Will Announce Earnings of -$0.24 Per Share
www.americanbankingnews.com - June 16 at 1:25 PM
Will the Brainstorm Cell Therapeutics Inc (NAQ:BCLI) share price keep rising?Will the Brainstorm Cell Therapeutics Inc (NAQ:BCLI) share price keep rising?
uk.finance.yahoo.com - June 16 at 8:32 AM
BrainStorm Granted SME Status by the European Medicines AgencyBrainStorm Granted SME Status by the European Medicines Agency
finance.yahoo.com - June 15 at 2:20 PM
BrainStorm to Present at the Raymond James Human Health Innovations ConferenceBrainStorm to Present at the Raymond James Human Health Innovations Conference
finance.yahoo.com - June 11 at 10:24 AM
BCLI: ALS Association and I AM ALS Awards $500,000 Grant; Potential Inclusion in Russell 3000 Index…BCLI: ALS Association and I AM ALS Awards $500,000 Grant; Potential Inclusion in Russell 3000 Index…
finance.yahoo.com - June 10 at 12:49 PM
The ALS Association, I AM ALS Award BrainStorm Cell Therapeutics $500,000 for ALS Biomarker StudyThe ALS Association, I AM ALS Award BrainStorm Cell Therapeutics $500,000 for ALS Biomarker Study
finance.yahoo.com - June 9 at 7:48 AM
Hedge Funds Warming Up To Brainstorm Cell Therapeutics Inc. (BCLI)Hedge Funds Warming Up To Brainstorm Cell Therapeutics Inc. (BCLI)
finance.yahoo.com - June 4 at 7:41 PM
BrainStorm to Participate in BIO Digital 2020BrainStorm to Participate in BIO Digital 2020
finance.yahoo.com - June 3 at 8:26 AM
BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020BrainStorm Announces that Pivotal Phase 3 Trial Remains on Track for Topline Data in Q4-2020
finance.yahoo.com - June 2 at 9:27 AM
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical ResearchBrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
finance.yahoo.com - May 27 at 8:55 AM
Does The Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Share Price Tend To Follow The Market?Does The Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Share Price Tend To Follow The Market?
finance.yahoo.com - May 18 at 7:46 AM
BrainStorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q1 2020 Results - Earnings Call TranscriptBrainStorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 8:39 PM
BCLI: The Countdown to Phase 3 ALS Data Begins…BCLI: The Countdown to Phase 3 ALS Data Begins…
finance.yahoo.com - May 8 at 3:31 PM
BrainStorm Cell Therapeutics EPS misses by $0.10BrainStorm Cell Therapeutics EPS misses by $0.10
seekingalpha.com - May 7 at 12:12 PM
BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn® for The European UnionBrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn® for The European Union
finance.yahoo.com - May 7 at 6:18 AM
BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in NeurologyBrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in Neurology
finance.yahoo.com - May 4 at 7:46 AM
BrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate UpdateBrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate Update
finance.yahoo.com - April 29 at 8:59 AM
BCLI: $1.5M Grant from Israel Innovation Authority…BCLI: $1.5M Grant from Israel Innovation Authority…
finance.yahoo.com - April 8 at 2:32 PM
BrainStorm Cell +4% premarket on $1.5M grantBrainStorm Cell +4% premarket on $1.5M grant
seekingalpha.com - April 3 at 7:36 AM
BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation AuthorityBrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority
finance.yahoo.com - April 3 at 7:36 AM
David Setboun Joins BrainStorm as Executive Vice President and Chief Operating OfficerDavid Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer
finance.yahoo.com - April 1 at 4:16 PM
Brainstorm Cell Therapeutics Inc.Brainstorm Cell Therapeutics Inc.
www.wsj.com - March 27 at 10:38 PM
Brainstorm Cell Therapeutics Inc. (BCLI)Brainstorm Cell Therapeutics Inc. (BCLI)
finance.yahoo.com - March 22 at 11:00 PM
Brainstorm Cell Therapeutics up 4% on capital raiseBrainstorm Cell Therapeutics up 4% on capital raise
seekingalpha.com - March 6 at 1:17 PM
BrainStorm Cell Therapeutics Raises $10.0 Million in Common Stock Sale at $8.00 Per ShareBrainStorm Cell Therapeutics Raises $10.0 Million in Common Stock Sale at $8.00 Per Share
finance.yahoo.com - March 6 at 1:17 PM
Fifth and Final Site Announced for BrainStorm’s Progressive Multiple Sclerosis Phase 2 Clinical TrialFifth and Final Site Announced for BrainStorm’s Progressive Multiple Sclerosis Phase 2 Clinical Trial
finance.yahoo.com - February 27 at 7:23 AM
Thinking about buying stock in Brainstorm Cell Therapeutics, HP, Plug Power, Virgin Galactic, or Zoom Video Communications?Thinking about buying stock in Brainstorm Cell Therapeutics, HP, Plug Power, Virgin Galactic, or Zoom Video Communications?
www.prnewswire.com - February 25 at 1:59 PM
BCLI: Phase 3 ALS Results in 4Q20…BCLI: Phase 3 ALS Results in 4Q20…
finance.yahoo.com - February 20 at 12:44 PM
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2019BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2019
finance.yahoo.com - February 18 at 7:31 AM
BrainStorm’s Chief Operating Officer to Present at Noble Capital Markets’ Sixteenth Annual Investor ConferenceBrainStorm’s Chief Operating Officer to Present at Noble Capital Markets’ Sixteenth Annual Investor Conference
finance.yahoo.com - February 17 at 4:20 AM
Brainstorm Cell Therapeutics (BCLI) Presents At 2020 BIO CEO & Investor Conference - SlideshowBrainstorm Cell Therapeutics (BCLI) Presents At 2020 BIO CEO & Investor Conference - Slideshow
seekingalpha.com - February 13 at 5:15 PM
BrainStorm Cell and FDA to discuss NurOwn regulatory pathways in ALSBrainStorm Cell and FDA to discuss NurOwn regulatory pathways in ALS
seekingalpha.com - February 11 at 7:33 AM
BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn(R) Regulatory Pathway for Approval in ALSBrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn(R) Regulatory Pathway for Approval in ALS
www.marketwatch.com - February 11 at 7:33 AM
BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn® Regulatory Pathway for Approval in ALSBrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn® Regulatory Pathway for Approval in ALS
finance.yahoo.com - February 11 at 7:33 AM
BrainStorm Cell Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Provide a Corporate UpdateBrainStorm Cell Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Provide a Corporate Update
finance.yahoo.com - February 10 at 9:25 AM
BrainStorm Receives Notice of Intention to Grant Additional EU patent for NurOwn®BrainStorm Receives Notice of Intention to Grant Additional EU patent for NurOwn®
finance.yahoo.com - January 29 at 9:13 AM
BrainStorm Cell Therapeutic’s COO and CMO, Dr. Ralph Kern, to Present at the 10th Annual California ALS Research SummitBrainStorm Cell Therapeutic’s COO and CMO, Dr. Ralph Kern, to Present at the 10th Annual California ALS Research Summit
finance.yahoo.com - January 21 at 3:52 PM
How Many Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Shares Did Insiders Buy, In The Last Year?How Many Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Shares Did Insiders Buy, In The Last Year?
finance.yahoo.com - January 17 at 9:51 AM
Reading Up On Brainstorm Cell TherapeuticsReading Up On Brainstorm Cell Therapeutics
seekingalpha.com - December 29 at 4:00 PM
NurOwn® Data Safety Monitoring Board Recommends MS Phase 2 Clinical Trial ContinueNurOwn® Data Safety Monitoring Board Recommends MS Phase 2 Clinical Trial Continue
finance.yahoo.com - December 19 at 8:20 AM
This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.